If you haven't completed our survey yet, there is still time. Today is the last day and it takes just 15 minutes to fill in. You will find links to the survey in 20 different languages here: surveymonkey.com/r/LuCESurvey20… Thank you. #LuCE #LungCancerEurope #LungCancer #LuCEMembers

🫁Time spent in lung cancer screening is associated with a stage shift at diagnosis in veterans, according to research by Dane Stewart, MD, of the KU Medical Center, and colleagues. ➡️Learn more: buff.ly/4bKglRQ #lcsm #lungcancer #ATS2024

The AI4LUNGS project was presented at Portugal's biggest annual 🔬💡science and innovation event, The Portuguese Science Summit - Ciência 2024. Encontro Ciência INESC TEC HaDEA #Ciencia24pt #CienciaViva #ai #lungcancer #eufunded #healthcare #lungs

Can Artificial Intelligence be an ally of democracy? 🤖 Our latest #Spotlight navigates through AI's role in managing large data volumes, combating misinformation, while highlighting the need for ethical considerations and avoiding biases 🌍 Read it now✨shorturl.at/u6VJv

Last month marked six months of our #HorizonEU project, AI4LUNGS, and the release of its first newsletter! At Future Needs, we manage the entire email marketing process for this project as part of our dissemination and communication services.

What is pseudonymised data? 🛡️🔐 Learn more about it from our technical partner Yonalink , and their Customer Success Manager, Sapir Balas. #pseudonymiseddata #lungcancer #personaldata #healthcare HaDEA

How is pseudonymised data used in healthcare? 🏥🔐Learn more about it from our technical partner Yonalink, and their Customer Success Manager, Sapir Balas. #pseudonymiseddata #lungcancer #personaldata #healthcare HaDEA

Join AI4LUNGS! INESC TEC is looking for two #PhD students to contribute to research on detecting and characterising radiological findings for various respiratory diseases, targeted by the project. #HorizonEU #research HaDEA #lungcancer inesctec.pt/pt/oportunidad…

What is the role of pseudonymised data in AI4LUNGS? 🫁 Learn more about it from our technical partner Yonalink, and their Customer Success Manager, Sapir Balas. #pseudonymiseddata #lungcancer #personaldata #healthcare HaDEA

Lung cancer is the deadliest cancer in the #EU. On #WorldLungCancerDay, we want to emphasise that early detection can significantly reduce mortality. At AI4LUNGS, we are revolutionising respiratory healthcare. Learn more: ai4lungs.eu

In AI4LUNGS, we prioritize ethical #AI in health. Based on WHO, OECD, UNESCO & EU guidelines, we adapt digital ethics principles to: 🎯 Address issues early 🤖 Ensure sustainable AI 🌍 Create human-centered solutions #AI4LUNGS #digitalethics #EUfunded #HaDEA @hadea

We hope that our solution will help those affected even better in the future with the power of AI.

Looking back at the AI4LUNGS kick-off meeting in Porto 6 months ago, it is amazing to see how much has happened since! 🚀 As summer draws to a close, we are excited about the upcoming activities and look forward to sharing more with you soon. HaDEA #lungcancer #healthcare

📰 The first patient has been dosed in the phase 3 IDeate-Lung02 trial, which is evaluating the efficacy and safety of investigational ifinatamab deruxtecan in patients with relapsed SCLC. ➡️ Learn more: buff.ly/3Xbtyib #SCLC #lcsm

We are seeking a PhD student to develop innovative signal processing and deep learning algorithms for digital lung auscultation, focusing on interstitial and inflammatory lung diseases. #HorizonEU #PhD #research inesctec.pt/pt/oportunidad…

In advance of September's World Conference on Lung Cancer and the annual Congress of the European Society for Medical Oncology, we wanted to re-share this really important interview with Lung Cancer Europe (LuCE) President Anne-Marie Baird. Read it here: ncbi.nlm.nih.gov/pmc/articles/P…

Our clinical partner Àlex Martínez from Vall d’Hebron Institute of Oncology (VHIO) elaborates on the key challenges in the current process of stratifying #LungCancer patients.

💥 The end of Pembro reign? Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: HARMONi-2 #WCLC24 #LCSM

Our partner, Future Needs participated in a workshop on Research Ethics and Medical Technology, organised by KIT Karlsruhe in Thessaloniki. The workshop provided an overview of essential ethical considerations for research in this rapidly evolving field. #ethics #digitalhealth

AI4LUNGS begins automating clinical data transfers for AI model development. Last week, @Yonalink and KPMG Israel joined INESC TEC and Gaia in Portugal to initiate the integration between Gaia's electronic health records (EHR) and Yonalink’s system. ai4lungs.eu/post/ai4lungs-…